Attached files

file filename
10-K - ANNUAL REPORT - Processa Pharmaceuticals, Inc.hwux_10k.htm
EX-31.1 - CERTIFICATION - Processa Pharmaceuticals, Inc.hwux_ex311.htm
EX-23.2 - AUDITORS' CONSENT - Processa Pharmaceuticals, Inc.hwux_ex232.htm
EX-23.1 - AUDITORS' CONSENT - Processa Pharmaceuticals, Inc.hwux_ex231.htm


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the annual report of Heatwurx, Inc. (the “Company”) on Form 10-K for the twelve months ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned principal executive officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:  June 19, 2017



/s/ John P. McGrain


John P. McGrain,

Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer)